Page last updated: 2024-09-04

pomalidomide and Waldenstrom Macroglobulinemia

pomalidomide has been researched along with Waldenstrom Macroglobulinemia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gauthier, J; Leleu, X; Wémeau, M; Yakoub-Agha, I	1
Bennett, BL; Mercurio, F; Schafer, PH; Stirling, DI; Zeldis, JB	1

Reviews

2 review(s) available for pomalidomide and Waldenstrom Macroglobulinemia

Article	Year
[IMiDs in hematology]. Bulletin du cancer, 2011, Volume: 98, Issue:8 Topics: Chronic Disease; Hematologic Neoplasms; Humans; Immunologic Factors; Lenalidomide; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Multiple Myeloma; Myelodysplastic Syndromes; Primary Myelofibrosis; Thalidomide; Waldenstrom Macroglobulinemia	2011
Potential new therapeutics for Waldenstrom's macroglobulinemia. Seminars in oncology, 2003, Volume: 30, Issue:2 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adjuvants, Immunologic; Clinical Trials as Topic; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytokines; Enzyme Inhibitors; Humans; JNK Mitogen-Activated Protein Kinases; Lenalidomide; Ligases; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Thalidomide; Ubiquitin-Protein Ligases; Waldenstrom Macroglobulinemia	2003

Article

Year

[IMiDs in hematology].

Bulletin du cancer, 2011, Volume: 98, Issue:8

Topics: Chronic Disease; Hematologic Neoplasms; Humans; Immunologic Factors; Lenalidomide; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Multiple Myeloma; Myelodysplastic Syndromes; Primary Myelofibrosis; Thalidomide; Waldenstrom Macroglobulinemia

2011

Potential new therapeutics for Waldenstrom's macroglobulinemia.

Seminars in oncology, 2003, Volume: 30, Issue:2

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adjuvants, Immunologic; Clinical Trials as Topic; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytokines; Enzyme Inhibitors; Humans; JNK Mitogen-Activated Protein Kinases; Lenalidomide; Ligases; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Thalidomide; Ubiquitin-Protein Ligases; Waldenstrom Macroglobulinemia

2003